531 related articles for article (PubMed ID: 33671965)
1. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
Peck AB; Nguyen CQ; Ambrus J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
[TBL] [Abstract][Full Text] [Related]
2. A MZB Cell Activation Profile Present in the Lacrimal Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-
Peck AB; Nguyen CQ; Ambrus JL
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682784
[TBL] [Abstract][Full Text] [Related]
3. Upregulated Chemokine and Rho-GTPase Genes Define Immune Cell Emigration into Salivary Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-
Peck AB; Nguyen CQ; Ambrus JL
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281229
[TBL] [Abstract][Full Text] [Related]
4. Marginal Zone B (MZB) Cells: Comparison of the Initial Identification of Immune Activity Leading to Dacryoadenitis and Sialadenitis in Experimental Sjögren's Syndrome.
Peck AB; Ambrus JL
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569583
[TBL] [Abstract][Full Text] [Related]
5. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
Nguyen CQ; Kim H; Cornelius JG; Peck AB
J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
[TBL] [Abstract][Full Text] [Related]
6. Central role for marginal zone B cells in an animal model of Sjogren's syndrome.
Shen L; Gao C; Suresh L; Xian Z; Song N; Chaves LD; Yu M; Ambrus JL
Clin Immunol; 2016 Jul; 168():30-36. PubMed ID: 27140729
[TBL] [Abstract][Full Text] [Related]
7. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
Jin JO; Shinohara Y; Yu Q
PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
[TBL] [Abstract][Full Text] [Related]
8. A Temporal Comparative RNA Transcriptome Profile of the Annexin Gene Family in the Salivary versus Lacrimal Glands of the Sjögren's Syndrome-Susceptible C57BL/6.NOD-
Peck AB; Ambrus JL
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233010
[TBL] [Abstract][Full Text] [Related]
9. Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.
Yin H; Nguyen CQ; Samuni Y; Uede T; Peck AB; Chiorini JA
Arthritis Res Ther; 2012 Feb; 14(1):R40. PubMed ID: 22369699
[TBL] [Abstract][Full Text] [Related]
10. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Chiorini JA; Peck AB
Lab Invest; 2011 Jan; 91(1):54-62. PubMed ID: 20856230
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
12. Role of sphingosine 1-phosphate in the pathogenesis of Sjögren's syndrome.
Sekiguchi M; Iwasaki T; Kitano M; Kuno H; Hashimoto N; Kawahito Y; Azuma M; Hla T; Sano H
J Immunol; 2008 Feb; 180(3):1921-8. PubMed ID: 18209090
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation.
Singh N; Chin I; Gabriel P; Blaum E; Masli S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314337
[TBL] [Abstract][Full Text] [Related]
14. Myd88 is required for disease development in a primary Sjögren's syndrome mouse model.
Kiripolsky J; McCabe LG; Gaile DP; Kramer JM
J Leukoc Biol; 2017 Dec; 102(6):1411-1420. PubMed ID: 28951424
[TBL] [Abstract][Full Text] [Related]
15. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.
Nguyen CQ; Sharma A; Lee BH; She JX; McIndoe RA; Peck AB
Arthritis Res Ther; 2009; 11(2):R56. PubMed ID: 19379516
[TBL] [Abstract][Full Text] [Related]
17. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue's extracellular milieu precede immune responses in Sjögren's syndrome.
Delaleu N; Nguyen CQ; Tekle KM; Jonsson R; Peck AB
Arthritis Res Ther; 2013 Oct; 15(5):R174. PubMed ID: 24286337
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
[TBL] [Abstract][Full Text] [Related]
20. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.
Humphreys-Beher MG; Peck AB
Arch Oral Biol; 1999 May; 44 Suppl 1():S21-5. PubMed ID: 10414851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]